Type 2 Diabetes Mellitus

FDA approval · 2015-03-03

FDA Approved: INVOKANA — Supplemental Application (Janssen Pharmaceuticals, Inc.)

The FDA approved a supplemental application for INVOKANA (canagliflozin) submitted by Janssen Pharmaceuticals, Inc., resulting in changes to…

CLINICAL_TRIALS trial_result · 2015-03-03

Clinical Trial Update: Safety, Tolerability, and Efficacy of ISIS-PTP1BRx in Type 2 Diabetes [Phase 2]

Phase 2 study evaluating the safety, tolerability, and efficacy of ISIS-PTP1BRx in people with type 2 diabetes mellitus and obesity.

FDA approval · 2015-03-03

FDA Approved: INVOKAMET — Supplemental Application (Janssen Pharmaceuticals, Inc.)

The FDA approved a supplemental application for INVOKAMET (canagliflozin/metformin HCl) from Janssen Pharmaceuticals.

CLINICAL_TRIALS research · 2015-03-03

Clinical Trial Update: Evaluation of a Nutritional Product for People With Type 2 Diabetes [NA]

A clinical trial evaluating a nutritional product for people with Type 2 diabetes has completed, sponsored by Abbott Nutrition.

CLINICAL_TRIALS trial_result · 2015-02-26

Clinical Trial Update: Diet and Exercise in Type 2 Diabetes - a Randomized Controlled Trial [NA]

This clinical trial update reports a completed randomized controlled trial evaluating the effects of diet and exercise in adults with type 2…

CLINICAL_TRIALS trial_result · 2015-02-26

Clinical Trial Update: Mechanistic Study of the Systolic Blood Pressure Lowering Effect of Dapagliflozin in Type 2 Diabetes [Phase 4]

This is a Phase 4 mechanistic clinical trial update assessing how dapagliflozin lowers systolic blood pressure in adults with type 2 diabete…

FDA approval · 2015-02-25

FDA Approved: TOUJEO — Original Application (Sanofi-Aventis U.S. LLC)

FDA approved Toujeo (insulin glargine) through its original application, establishing a concentrated long-acting insulin product for glycemi…

FDA approval · 2015-02-25

FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)

FDA approved a supplemental application for Lantus SoloStar (insulin glargine) from sanofi-aventis U.S. LLC. The insulin product is used to …

FDA approval · 2015-02-25

FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)

The FDA approved a supplemental application for insulin lispro from Eli Lilly, updating approval details for this product.

FDA approval · 2015-02-25

FDA Approved: SYMLINPEN — Supplemental Application (AstraZeneca Pharmaceuticals LP)

FDA approved a supplemental application for SymlinPen (pramlintide acetate) by AstraZeneca Pharmaceuticals LP.

FDA approval · 2015-02-25

FDA Approved: NOVOLIN N — Supplemental Application (Novo Nordisk)

FDA approved a supplemental application for NOVOLIN N (human insulin) from Novo Nordisk.

FDA approval · 2015-02-25

FDA Approved: LIRAGLUTIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for liraglutide (NDA 022341).

FDA approval · 2015-02-25

FDA Approved: PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)

The FDA approved a supplemental application for a generic pioglitazone hydrochloride and metformin hydrochloride combination product intende…

FDA approval · 2015-02-25

FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)

The FDA has approved a supplemental application for NOVOLOG (insulin aspart) from Novo Nordisk. The approval relates to changes to the produ…

FDA approval · 2015-02-25

FDA Approved: APIDRA — Supplemental Application (sanofi-aventis U.S. LLC)

FDA approved a supplemental application for APIDRA (insulin glulisine) submitted by Sanofi-Aventis U.S. LLC.

FDA approval · 2015-02-25

FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)

FDA approves a supplemental application for Humalog Mix75/25 (insulin lispro) from Eli Lilly and Company.

FDA approval · 2015-02-25

FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)

The FDA approved a supplemental application for Humalog Mix50/50 KwikPen (insulin lispro) from Eli Lilly, expanding the approved formulation…

FDA approval · 2015-02-25

FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)

The FDA approved a supplemental application for Humulin R (insulin human) from Eli Lilly and Company.